© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
HIV
Study Looks at How an HIV Protein Can Alter Immune Cells and Fuel Chronic Inflammation
December 02, 2022
The findings of research results published in Cells Reports implicate the Nef protein as a possible cause of disease-causing inflammation that persists even when an HIV infection is controlled.
Howard University Professor Awarded Grant to Harness Nanotechnology for HIV Cure
December 01, 2022
HIV hides out and replicates in the spleen, the lymph nodes and other reservoirs. Emmanuel Okala hopes to develop nanotechnology that will flush it out.
ART Works. But Researchers are Pursuing a Cure for HIV.
November 04, 2022
Results of a small study published in Nature Medicine show that early treatment with a monoclonal antibody might be part of a strategy to clear an HIV infection.
Positive Findings for Biktarvy Presented at HIV Research Meeting in Glasgow
November 02, 2022
Gilead Sciences reported results from several studies of its antiretroviral.
They Are Still There. Barriers to HIV Testing and Care.
November 01, 2022
In a conversation with with Managed Healthcare Executive®, Genoa Healthcare Sales Director Jennifer Finocchiaro discusses social determinants of health, the LGBTQ+ community and the demographic contours of the HIV/AIDS epidemic
What Is the Best Strategy for Curbing HIV in Uganda? Study Seeks to Answer That Question.
October 06, 2022
Fred Ssewamala, Ph.D., a Washington University professor and researchers, has been awarded a $3.2 million grant to study HIV intervention strategies among Ugandan young people.
Monkeypox, HIV Co-Infection Is Common, According to CDC Study
October 05, 2022
About 40% of people monkeypox also had HIV, according to a CDC study that included almost 2,000 monkeypox cases in the U.S. that occurred during the first two months of the outbreak.
University of Miami Researchers Are Studying Links Between COVID-19, HIV and Evolution of New Variants
October 05, 2022
People with HIV are more susceptible to getting COVID-19 and having a severe case. Researchers at the University of Miami Miller of School of Medicine are heading up an NIAID-funded study that will use artificial intelligence to observe the overlap of the two infectious diseases and the evolution new variants of the SARS-CoV-2 virus that causes COVID-19.
HIV Care and the Trans Community | A Brief Conversation With Theodore Gideonse, Ph.D.
September 20, 2022
Ryan White funds can make HIV care affordable, even free, but there needs to be more outreach to the trans community, says University of California, Irvine, professor.
How President Biden Can Meet His Pledge to End HIV by 2030
September 19, 2022
Preexposure prophylaxis and emphasizing the U=U (undetectable = untransmittable) message are central to the efforts to end the HIV epidemic, a goal that the Biden administration picked up from the Trump administration.